Steven J. Manyak

The proteasome inhibitor PS-341 markedly enhances sensitivity of multiple myeloma tumor cells to chemotherapeutic agents.

Hans Mark, Hank H. Yang, Kimberly M. Parker et al. · PubMed · 2003 · 418 citations

Chemotherapeutic Agents, Tumor Biology, Hematological Malignancy +11

Identification of polymorphisms of the IκBα gene associated with an increased risk of multiple myeloma

Kimberly M. Parker, Hans Mark, Steven J. Manyak et al. · Cancer Genetics and Cytogenetics · 2002 · 35 citations

Hematological Malignancy, Medicine, Genetics +8

LAGλ-1: A clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma

Richard A. Campbell, Steven J. Manyak, Honghao Yang et al. · International Journal of Oncology · 2006 · 30 citations · Full text

Immunology, Immunoediting, Immunotherapy +17

Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth

Haiming Chen, Melinda S. Gordon, Richard A. Campbell et al. · Blood · 2007 · 26 citations · Full text

Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status

Howard Yeh, Haiming Chen, Steven J. Manyak et al. · British Journal of Haematology · 2006 · 16 citations · Full text

Ptn Serum Levels, Immunology, Pathology +17